Pretreatment with 5-FU enhances cisplatin cytotoxicity in head and neck squamous cell carcinoma cells Kei IjichiMakoto AdachiKanji Ishizaki Original Article 13 December 2007 Pages: 745 - 752
The role of topoisomerases and RNA transcription in the action of the antitumour benzonaphthyridine derivative SN 28049 David J. A. BridewellAndrew C. G. PorterBruce C. Baguley Original Article 03 January 2008 Pages: 753 - 762
A phase II study of capecitabine plus gemcitabine in patients with locally advanced or metastatic pancreatic cancer Hong Suk SongYoung Rok DoSi Young Kim Original Article 03 January 2008 Pages: 763 - 768
An in vitro and in vivo study of the combination of the heat shock protein inhibitor 17-allylamino-17-demethoxygeldanamycin and carboplatin in human ovarian cancer models Udai BanerjiNivedita SainPaul Workman Original Article 10 January 2008 Pages: 769 - 778
Clinical pharmacokinetics of bevacizumab in patients with solid tumors Jian-Feng LuRene BrunoJacques Gaudreault Original Article 19 January 2008 Pages: 779 - 786
Toxicity and antitumor activity of the vitamin D analogs PRI-1906 and PRI-1907 in combined treatment with cyclophosphamide in a mouse mammary cancer model Joanna WietrzykDmitry NevozhayAndrzej Kutner Original Article 10 January 2008 Pages: 787 - 797
7-Chloro-6-piperidin-1-yl-quinoline-5,8-dione (PT-262), a novel synthetic compound induces lung carcinoma cell death associated with inhibiting ERK and CDC2 phosphorylation via a p53-independent pathway Tzu-Sheng HsuChinpiao ChenJui-I Chao Original Article 10 January 2008 Pages: 799 - 808
7-Chloro-6-piperidin-1-yl-quinoline-5,8-dione (PT-262), a novel synthetic compound induces lung carcinoma cell death associated with inhibiting ERK and CDC2 phosphorylation via a p53-independent pathway Tzu-Sheng HsuChinpiao ChenJui-I Chao Erratum 12 March 2008 Pages: 809 - 809
Celecoxib inhibits growth of tumors in a syngeneic rat liver metastases model for colorectal cancer Pieter de HeerMaro H. SandelPeter J. K. Kuppen Original Article Open access 05 February 2008 Pages: 811 - 819
Cytotoxic effects of treosulfan and busulfan against leukemic cells of pediatric patients Doreen MunkeltUlrike KoehlRuth Esser Original Article 02 February 2008 Pages: 821 - 830
2-Methoxyestradiol inhibits hepatocellular carcinoma cell growth by inhibiting Cdc25 and inducing cell cycle arrest and apoptosis Siddhartha KarMeifang WangBrian I. Carr Original Article 02 February 2008 Pages: 831 - 840
Continuous ambulatory peritoneal dialysis: pharmacokinetics and clinical outcome of paclitaxel and carboplatin treatment Joan B. HeijnsMaria E. L. van der BurgWalter J. Loos Original Article Open access 19 January 2008 Pages: 841 - 847
S-1 monotherapy as first-line treatment in patients with advanced biliary tract cancer: a multicenter phase II study Junji FuruseTakuji OkusakaAkihiro Funakoshi Original Article 23 January 2008 Pages: 849 - 855
Curcumin attenuates EGF-induced AQP3 up-regulation and cell migration in human ovarian cancer cells Chao JiCong CaoYinsheng Wan Original Article 23 January 2008 Pages: 857 - 865
Inhibition of P-glycoprotein and multidrug resistance protein 1 by dietary phytochemicals Tomohiro NabekuraTakeshi YamakiShuji Kitagawa Original Article 19 January 2008 Pages: 867 - 873
Phase II trial of sequential paclitaxel and 1 h infusion of bryostatin-1 in patients with advanced esophageal cancer Geoffrey Y. KuDavid H. IlsonGary K. Schwartz Original Article 13 February 2008 Pages: 875 - 880
In vitro and in vivo evaluation of combined calcitriol and cisplatin in dogs with spontaneously occurring tumors Kenneth M. RassnickJosephia R. MuindiDonald L. Trump Original Article 02 February 2008 Pages: 881 - 891
2-Methoxyestradiol reverses doxorubicin resistance in human breast tumor xenograft Samar S. AzabSalama A. SalamaAshraf B. Abdel-Naim Original Article 06 February 2008 Pages: 893 - 902
Trastuzumab and gemcitabine as salvage therapy in heavily pre-treated patients with metastatic breast cancer Rupert BartschCatharina WenzelGuenther G. Steger Original Article 07 February 2008 Pages: 903 - 910
Cantuzumab mertansine in a three-times a week schedule: a phase I and pharmacokinetic study Jordi RodonMitchell GarrisonAnthony W. Tolcher Clinical Trial Report 27 February 2008 Pages: 911 - 919
Androgen receptor expression in prostate cancer stem cells: is there a conundrum? Nima SharifiElaine M. HurtWilliam L. Farrar Short Communication 13 December 2007 Pages: 921 - 923
Oxaliplatin-induced immune mediated thrombocytopenia Muhammad S. BegRami S. KomrokjiMalek M. Safa Short Communication 19 January 2008 Pages: 925 - 927
Successful treatment of non-islet cell tumor hypoglycemia in hepatocellular carcinoma with doxorubicin Thatchai Kampitak Letter to the Editor 16 February 2008 Pages: 929 - 930